Trial intelligence / Profile preview

Preoperative celecoxib and gabapentin regimens for postoperative pain after total knee arthroplasty

IRCT20200217046523N10Phase 3Completed

Sponsor
Isfahan University of Medical Sciences
Start
Feb 2021
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of celecoxib, gabapentin and dexamethasone in postoperative pain (4 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Postoperative pain intensity. Started Feb 2021; status: completed.

02

Drugs

celecoxibgabapentindexamethasone
03

Conditions

postoperative pain

Beyond the preview

Go deeper on IRCT20200217046523N10.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20200217046523N10.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call